Identification and Characterization of a Novel Glycoprotein Core Xylosidase from the Bacterium Elizabethkingia Meningoseptica

Linlin Hou,Tiansheng Li,Haiying Chen,Danfeng Shen,Mengjie Li,Yameng Guo,Lin Zou,Lei Wang,Guiqin Sun,Weiming Cai,Jinbiao Ma,Li Chen

DOI: https://doi.org/10.1016/j.bbrc.2019.07.035

IF: 3.1

2019-01-01

Biochemical and Biophysical Research Communications

Abstract:Although core xylose on glycoproteins has been implicated in allergy, infection and other biological processes, research on core xylose modification is rare. The lack of a β-d-xylosidase that can catalytically remove the core xylose directly from glycoproteins is a reason for this. Through functional genomic analysis, we identified a glycoprotein core xylosidase and named it gpcXase I. gpcXase I is located immediately downstream of glycoprotein core fucosidase cFase I in Elizabethkingia meningoseptica. These two genes form a functional operon for glycoprotein core modifications. Three acidic residues (Asp-200, Asp-304 and Glu-649) were identified as key catalytic sites for gpcXase I activity, suggesting a unique triacdic mechanize for its activity. Asp-200 was identified a novel and essential base catalysts in the catalytic process, Asp-304 and Glu-649 was function as catalytic nucleophiles and acid catalysts, respectively. In addition, IgE-specific reactions were detected in 55% of serum samples collected from 40 allergic patients, and the reactions were significantly attenuated by removal of the core xylose of the allergen by treatment with gpcXase I. gpcXase I is a novel tool for basic and clinical glycomics.